Torigen Pharmaceuticals Signs First Distribution Agreement with Victor Medical Company
Share Article
Agreement will increase Torigen’s channel partnerships bringing the company’s autologous pet cancer vaccine to west coast veterinary clinics FARMINGTON, Conn. (PRWEB) June 09, 2021
Torigen Pharmaceuticals Inc., a commercial-stage animal health biologics company, today announced that it has signed a distribution agreement with Victor Medical Company to expand U.S. channel partnerships of its patented experimental autologous cancer vaccine for companion animals. Victor Medical is the largest privately-owned veterinary distributor in California, Arizona, Nevada, and Oregon, providing veterinary clinics with access to quality products and exceptional service.
This is the first distribution agreement for Torigen, whose experimental autologous cancer vaccine uses an animal’s own tumor to stimulate a pet’s immu
Unnatural deaths: Leopard carcasses found in Nanjangud starofmysore.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from starofmysore.com Daily Mail and Mail on Sunday newspapers.
Four-year-old female giraffe Bubli dies in Hyderabad Zoo ANI | Updated: May 27, 2021 23:10 IST
Hyderabad (Telangana) [India], May 27 (ANI): Bubli, a four-year and 3 months old female giraffe, died after a brief bout of pneumonia at the Nehru Zoological Park in Hyderabad, informed officials on Thursday.
Bubli had been brought to the Hyderabad zoo in 2019, as part of an animal exchange program with the Alipore Zoological Garden in Kolkata. As per preliminary post-mortem reports, Bubli is suspected to be suffering with Pneumonia and accordingly treatment was being provided since last week, an official statement of Nehru Zoological Park said.
Samples have been collected and sent to Veterinary Biological and Research Institute (VBRI) for further detailed examination. (ANI)
AP Photo/Alex Brandon
During Dr. Anthony Fauci’s testimony before a Senate committee Tuesday he was grilled by Sen. Rand Paul (R-KY) about gain-of-function viral research purportedly done in this country or in China through National Institutes of Health (NIH) grants, and he seemed completely unaware of the extent of such research done in this country. The term “gain-of-function” refers to the enhancement of viruses to make them more deadly and transmissible, and that research is ostensibly undertaken here in the United States so that we can develop defensive treatments for viruses that may have been weaponized through another country’s gain-of-function research.
Kindred Biosciences Announces First Quarter 2021 Financial Results
News provided by
Share this article
Share this article
SAN FRANCISCO, May 11, 2021 /PRNewswire/ Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the first quarter ended March 31, 2021 and provided updates on its programs. For the first quarter 2021, KindredBio reported net revenues of $2.4 million and a net loss of $9.7 million, or $0.24 per share. We had a strong start to the year, announcing positive results in a new long-acting interleukin-31 antibody program that has the potential to become a best-in-class therapeutic, alongside the acceptance of efficacy data for our parvovirus monoclonal antibody program. With cash runway now through the end of 2023, we are well-positioned to realize the value of our promising late-stage pipeline, said KindredBio s Chief Executive Officer, Richard Chin, M.D.